drugset
drugset / Trial / NCT00861718

Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers

NCT00861718 ↗

Phase 1 Completed 40 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blind

Summary

Multiple Ascending Dose Study

Timeline

Start
2009-04
Primary completion
—
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD7268 Small molecule — Oral

Indications

No indication recorded.